Cite
T cell (CD3+) chimerism after non-myeloablative allogeneic hematopoietic stem cell transplantation (NMHSCT)
MLA
Sobecks, R., et al. “T Cell (CD3+) Chimerism after Non-Myeloablative Allogeneic Hematopoietic Stem Cell Transplantation (NMHSCT).” Biology of Blood & Marrow Transplantation, vol. 10, Feb. 2004, p. 41. EBSCOhost, https://doi.org/10.1016/j.bbmt.2003.12.197.
APA
Sobecks, R., Theil, K., Rybicki, L., Kuczkowski, E., Warshawsky, I., Tubbs, R., Kalaycio, M., Pohlman, B., Andresen, S., & Bolwell, B. J. (2004). T cell (CD3+) chimerism after non-myeloablative allogeneic hematopoietic stem cell transplantation (NMHSCT). Biology of Blood & Marrow Transplantation, 10, 41. https://doi.org/10.1016/j.bbmt.2003.12.197
Chicago
Sobecks, R., K. Theil, L. Rybicki, E. Kuczkowski, I. Warshawsky, R. Tubbs, M. Kalaycio, B. Pohlman, S. Andresen, and B.J. Bolwell. 2004. “T Cell (CD3+) Chimerism after Non-Myeloablative Allogeneic Hematopoietic Stem Cell Transplantation (NMHSCT).” Biology of Blood & Marrow Transplantation 10 (February): 41. doi:10.1016/j.bbmt.2003.12.197.